Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  New England Journal of Medicine

• Publication date

  1996-03-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199603143341102PMID 8594426
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.

  1995cited by this paper
• Optimal oral anticoagulant therapy in patients with mechanical heart valves.

  1995cited by this paper
• Resistance to activated protein C as a basis for venous thrombosis.

  1994cited by this paper
• Comparison of Once-Daily Subcutaneous Fragmin® with Continuous Intravenous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis

  1994cited by this paper
• A Simple Ultrasound Approach for Detection of Recurrent Proximal‐Vein Thrombosis

  1993cited by this paper
• A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients.

  1993cited by this paper
• Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.

  1992cited by this paper
• Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis.

  1992cited by this paper
• Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.

  1992cited by this paper
• Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

  1992cited by this paper
• Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance

  1992cited by this paper
• Subcutaneous Low Molecular Weight Heparin versus Subcutaneous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis: a Polish Multicenter Trial

  1992cited by this paper
• Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis.

  1992cited by this paper
• The Mos Short-Form General Health Survey: Single Item vs Multiple Measures of Health-Related Quality of Life: Some Nuances

  1992cited by this paper
• Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

  1991cited by this paper
• The Impact of Long-term Warfarin Therapy on Quality of Life: Evidence From a Randomized Trial

  1991cited by this paper
• The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.

  1991cited by this paper
• The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II.

  1991cited by this paper
• Oral anticoagulant drugs.

  1991cited by this paper
• Diagnosis of venous thrombosis.

  1991cited by this paper
• Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).

  1990cited by this paper
• Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist.

  1990cited by this paper
• Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.

  1990cited by this paper
• Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.

  1986cited by this paper
• Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

  1986cited by this paper
• Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits.

  1982cited by this paper

• 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2026cites this paper
• Emerging trends in anticoagulation therapy: a bibliometric analysis of DOACs and endogenous coagulation pathway inhibitors

  2025cites this paper
• Anticoagulants: From chance discovery to structure-based design.

  2025cites this paper
• Clinical Predictors of Warfarin Response Among Patients with Atrial Fibrillation: Evidence from the Middle Eastern JoFib Study.

  2025cites this paper
• Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice

  2024cites this paper
• Examining the controversies in venous thromboembolism prophylaxis for vascular surgery patients: A critical review.

  2024cites this paper
• Outpatient Management of Venous Thromboembolism in Acute Phase

  2024cites this paper
• Clinical Studies with Anticoagulants that Have Changed Clinical Practice

  2023cites this paper
• Disposition of emergency department patients with acute pulmonary embolism after ambulance arrival

  2023cites this paper
• Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications

  2022cites this paper
• How we changed our approach to venous thromboembolism

  2022cites this paper
• American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.

  2021cites this paper
• Home Treatment Compared to Initial Hospitalization in Normotensive Patients with Acute Pulmonary Embolism in the Netherlands: A Cost Analysis

  2021cites this paper
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.

  2021cites this paper
• The Impact of Using Mobile Applications on Health Outcomes in Patient Self-Management of Oral Anticoagulation Therapy

  2021cites this paper
• Site of Deep Venous Thrombosis and Age in the Selection of Patients in the Emergency Department for Hospitalization Versus Home Treatment.

  2021cites this paper
• Cost-effectiveness analysis for the parenteral anticoagulants in Jordan

  2021cites this paper
• Deep Vein Thrombosis and Pulmonary Embolus Thrombolysis and Endovascular Treatment

  2021cites this paper
• Outpatient treatment of emergency department patients diagnosed with venous thromboembolism

  2021cites this paper
• Comparison of Hospital-at-Home models: a systematic review of reviews

  2021cites this paper
• Current practice patterns of outpatient management of acute pulmonary embolism: A post-hoc analysis of the YEARS study.

  2020cites this paper
• Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE)

  2020cites this paper
• Antithrombotika und Antihämorrhagika

  2020cites this paper
• Platelets and Metastasis: New Implications of an Old Interplay

  2020cites this paper
• Parnaparin in surgery, vascular surgery and associated disciplines

  2020cites this paper
• Mesenterialvenenthrombose

  2020cites this paper
• Treatment of thrombosis

  2020cites this paper
• American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

  2020cites this paper
• European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis.

  2020cites this paper
• Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer

  2020cites this paper
• Pulmonary Embolism

  2020cites this paper
• Low Molecular Weight Heparin

  2020cites this paper
• The relationship between DOAC levels and clinical outcomes: The measures tell the tale

  2020cites this paper
• Effects of Methanol Extract of Illicium verum Hook.f on Coagulation Parameters in Rabbits

  2020cites this paper
• Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis.

  2020cites this paper
• Operative and peri‐operative considerations in the management of brain metastasis

  2019cites this paper
• Fifty years of research on antithrombotic therapy: Achievements and disappointments.

  2019cites this paper
• Home treatment of patients with cancer-associated venous thromboembolism - An evaluation of daily practice.

  2019cites this paper
• [What route of care to propose for patients with proximal DVT? Who to hospitalise?]

  2019cites this paper
• Direct Oral Anticoagulant Drugs: On the Treatment of Cancer-Related Venous Thromboembolism and their Potential Anti-Neoplastic Effect

  2019cites this paper
• Health-related quality of life after adverse bleeding events associated with antithrombotic drug therapy - A systematic review.

  2019cites this paper
• Article 3

  2019cites this paper
• Development and Evaluation of a Pharmacist-Driven Screening Tool to Identify Patients Presenting to the Emergency Department Who Are Eligible for Outpatient Treatment of Deep Vein Thrombosis

  2019cites this paper
• Anticoagulant acrobatics: Surviving the global heparin shortage in the emergency department.

  2019cites this paper
• Cost-Effectiveness of Extended Thromboprophylaxis in Patients Undergoing Colorectal Surgery from a Canadian Health Care System Perspective.

  2019cites this paper
• Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.

  2019cites this paper
• Characteristics of software used in self-management of vitamin K antagonist therapy: A systematic review

  2019cites this paper
• Antithrombin–Heparin Complexes

  2019cites this paper
• Multicenter Implementation of a Novel Management Protocol Increases the Outpatient Treatment of Pulmonary Embolism and Deep Vein Thrombosis.

  2018cites this paper
• Thromboembolic Disease

  2018cites this paper
• Emergency Department Patient Satisfaction with Treatment of Low-risk Pulmonary Embolism

  2018cites this paper
• Transitioning Between Anticoagulants

  2018cites this paper
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.

  2018cites this paper
• Effect of anticoagulants on admission rates and length of hospital stay for acute venous thromboembolism: A systematic review of randomized control trials.

  2018cites this paper
• Therapeutic approach for patients with venous thromboembolism attended in emergency departments during routine clinical practice: the EDITH study.

  2018cites this paper
• Chapter 60 – Deep Vein Thrombosis: Prophylaxis and Treatment

  2018cites this paper
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

  2018cites this paper
• Systematic Review of Real-World Studies Evaluating Characteristics Associated With or Programs Designed to Facilitate Outpatient Management of Deep Vein Thrombosis

  2018cites this paper
• Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins.

  2017cites this paper
• Effectiveness and Tolerability of Anticoagulants for Thromboprophylaxis after Major Joint Surgery: a Network Meta-Analysis

  2017cites this paper
• Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study

  2017cites this paper
• Catheter-directed thrombolysis for deep venous thrombosis might be cost-effective , but for whom ?

  2017cites this paper
• Therapeutic monitoring of unfractionated heparin – trials and tribulations

  2017cites this paper
• Rivaroxaban program for acute venous thromboembolism upon ED discharge, with focus on utility of commercially available dose pack☆

  2017influential citation
• Best Clinical Practice: Controversies in Outpatient Management of Acute Pulmonary Embolism.

  2017cites this paper
• Chapter 145 Antithrombotic and Thrombolytic Therapy

  2017cites this paper
• Early discharge hospital at home.

  2017cites this paper
• Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis

  2017cites this paper
• Outpatient Treatment of Deep Vein Thrombosis in the United States: The Reasons for Geographic and Racial Differences in Stroke Study

  2017cites this paper
• Milestone 7: A breakthrough for out-of-hospital treatment of thrombosis.

  2017cites this paper
• Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice

  2017cites this paper
• The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event

  2017cites this paper
• THE EFFECT OF APROTININ ON RENAL INJURY IN AN EXPERIMENTAL MODEL OF AORTIC ISCHEMIA-REPERFUSION

  2017cites this paper
• Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.

  2017cites this paper
• In-Hospital Mortality with Deep Venous Thrombosis.

  2017cites this paper
• COMPARISON OF TWICE DAILY LOW-MOLECULAR-WEIGHT HEPARIN VERSUS ONCE DAILY REGIMEN FOR THE TREATMENT OF DEEP VEIN THROMBOSIS

  2017cites this paper
• Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.

  2017cites this paper
• Early ambulation versus immobilization in the management of patients with distal deep venous thrombosis

  2017cites this paper
• Overview of the treatment of lower extremity deep vein thrombosis ( DVT )

  2017cites this paper
• Venous Thromboembolism: Diagnosis and Treatment

  2017cites this paper
• Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

  2017cites this paper
• Anticoagulation following anterior cruciate ligament reconstruction

  2017cites this paper
• Arrive: A retrospective registry of Indian patients with venous thromboembolism

  2016cites this paper
• Home Treatment of Deep Venous Thrombosis According to Comorbid Conditions.

  2016cites this paper
• To promote endothelial function: The elusive link between physical therapy of venous thromboembolism and improved outcomes?

  2016cites this paper
• Home treatment of deep venous thrombosis

  2016cites this paper
• Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage

  2016cites this paper
• Treating patients with cancer and acute venous thromboembolism

  2016cites this paper
• Prospective Assessment of a Nomogram for the Initiation of Oral Anticoagulation Therapy for Outpatient Treatment of Venous Thromboembolism

  2016cites this paper
• Chapter 11 – Thromboembolic Disease in Cancer

  2016cites this paper
• Bein- und Beckenvenenthrombose (TVT).

  2016cites this paper
• Evaluation of the deep vein recanalisation and function after low molecular weight heparin (calcium nadroparine) therapy of deep vein thrombosis. Preliminary report

  2016cites this paper
• Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial.

  2016cites this paper
• Home treatment of acute pulmonary embolism

  2016cites this paper
• A Comprehensive Overview of Direct Oral Anticoagulants for the Management of Venous Thromboembolism

  2016cites this paper
• Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research Study

  2016cites this paper
• Management of venous thromboembolism: an update

  2016cites this paper
• Case Fatality Rate and Population Mortality Rate from Pulmonary Embolism and Deep Venous Thrombosis

  2016cites this paper
• Preparation, Properties and Preclinical Pharmacokinetics of Low Molecular Weight Heparin-modified Isoliquiritigenin-loaded Solid Lipid Nanoparticle

  2016cites this paper
• BACTERIOLOGICAL ANALYSIS OF WATER CONSUMED BY THE POPULATION OF IRHAMBI / KATANA GROUPING, SOUTH KIVU, DR CONGO

  2016cites this paper